tbuckley/cabot-search huggingface dataset:
Reviving clinical pharmacology: Emma Baker
Authors: Helen Jones
Journal: BMJ (2020)

Pharmacological Society-are a result of serendipity and the fact that she faced some obstacles early in her career."I was very naïve when I was young and I thought, 'I don't want to do a BSc, I just want to be a doctor,' so I didn't do a BSc and that limited my choices," she says."I had real difficulty getting into hospital medicine and I was incensed by that, so I overcompensated.""I eventually got a job at Salford's Hope Hospital and met Leslie Turnberg, who
Subcutaneous Daratumumab (DARA SC) + Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Asian Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Subgroup Analysis from the Phase 3 Andromeda Study
Authors: Kenshi Suzuki, Ashutosh D. Wechalekar, Kihyun Kim, Chihiro Shimazaki, Jin Seok Kim, Takayuki Ikezoe, Chang-Ki Min, Fude Zhou, Shinsuke Iida, Nagaaki Katoh, Tomoaki Fujisaki, Ho-Jin Shin, NamPhuong Tran, Xiang Qin, Sandra Y. Vasey, Brenda Tromp, Brendan M. Weiss, Jessica Vermeulen, Raymond L. Comenzo, Efstathios Kastritis, Jin Lu
Journal: Blood (2020)
Outcomes after Autologous Stem Cell Transplant in Patients with Relapsed Multiple Myeloma
Authors: Christopher Lemieux, Juliana Craig, David Iberri, Sally Arai, Laura J. Johnston, Robert Lowsky, Lori S. Muffly, Parveen Shiraz, Michaela Liedtke, Andrew R. Rezvani, Matthew J. Frank, Wen-Kai Weng, Everett H Meyer, Judith A Shizuru, Robert S. Negrin, David B. Miklos, Surbhi Sidana
Journal: Blood (2020)
Mosunetuzumab, a Novel CD20/CD3 Bispecific Antibody, in Combination with CHOP Confers High Response Rates in Patients with Diffuse Large B-Cell Lymphoma
Authors: Tycel J. Phillips, Adam J Olszewski, Javier Munoz, Tae Min Kim, Dok Hyun Yoon, Richard Greil, Jason Westin, Ulrich Jaeger, Miguel Canales, Cindy Chen, Betsy Althaus, Carol O'Hear, Raluca Negricea, Yuying Xie, Ronald McCord, Enkhtsetseg Purev, Anusha Vallurupalli
Journal: Blood (2020)
Predictors of Cytopenia after Treatment with Axicabtagene Ciloleucel in Patients with Large Cell Lymphoma
Authors: Lorena Panaite, Jordan Gauthier, Paula Perkins, Jenna Voutsinas, Qian Vicky Wu, Angela Kirk, Aisling Cearley, Erin Mullane, Ryan D. Cassaday, Hans-Peter Kiem, Victor A. Chow, Ryan C. Lynch, Chaitra S. Ujjani, Stephen D. Smith, Ajay K. Gopal, Brian G. Till, Cameron J. Turtle, David G. Maloney, Mazyar Shadman
Journal: Blood (2020)
High Clonal Complexity of Resistance Mechanisms Occurring at Progression after Single-Agent Targeted Therapy Strategies in Chronic Lymphocytic Leukemia
Authors: Ella R Thompson, Tamia Nguyen, Yamuna Kankanige, Mary Ann Anderson, Sasanka M. Handunnetti, Rachel Thijssen, Paul Sung-Hao Yeh, Constantine S. Tam, John F. Seymour, Andrew W Roberts, David Alan Westerman, Piers Blombery
Journal: Blood (2020)
Abstract 13236: Impaired Global Longitudinal Strain is Associated With Poor Prognosis Even in Patients With Preserved Ejection Fraction After Myocardial Infarction
Authors: Katsuomi Iwakura, Atsunori Okamura, Yasushi Koyama, Koichi Inoue, Mutsumi Iwamoto, Hiroyuki Nagai, Yuko Hirao, Koji Tanaka, Takafumi Oka, Nobuaki Tanaka, Yuichi Ninomiya, Masato Okada, Akinori Sumiyoshi, Hiroyuki Inoue, Kota Tanaka, Kohtaro Takayasu, Ryo Kitagaki, Kenshi Fujii
Journal: Circulation (2018)

Background: Global longitudinal strain (GLS) measured by 2D speckle tracking is more sensitive for the changes in left ventricular (LV) systolic function than LV ejection fraction (LVEF), and it co...
Clonal Expansion of Mutant p53 Clones By MDM2 Inhibition in Acute Myeloid Leukemias
Authors: Yuki Nishida, Rafael Heinz Montoya, Kiyomi Morita, Tomoyuki Tanaka, Feng Wang, Koichi Takahashi, Jo Ishizawa, Prasanna Kumar, Parul Patel, Cedric E. Dos Santos, Courtney D. DiNardo, Michael Andreeff
Journal: Blood (2020)
Constructing and evaluating caspase-activatable adeno-associated virus vector for gene delivery to the injured heart
Authors: Mitchell J. Brun, Kefan Song, Byunguk Kang, Cooper Lueck, Weitong Chen, Kaitlyn Thatcher, Erhe Gao, Walter J. Koch, Joy Lincoln, Sudarsan Rajan, Junghae Suh
Journal: Journal of Controlled Release (2020)
Quality of Life, Tryptophan Metabolites, and Neurotoxicity Assessments of Patients with Relapsed or Refractory B Cell Malignancies Undergoing CAR 20/19 - T Cell Therapy
Authors: Jennifer M Knight, Igli Arapi, Aniko Szabo, Sharon Yim, Garrett Sauber, Cecilia Hillard, Parameswaran Hari, Nirav N. Shah
Journal: Blood (2020)
Comparative Analysis of Clinical Prediction Scores in Acquired Thrombotic Thrombocytopenic Purpura: The Superiority of Plasmic Score
Authors: Daniela Pereira Coelho, Bárbara Almeida Marques, Adriana Roque, Jose Pedro Carda, Patrícia Martinho, Teresa Fidalgo, Maria Leticia Ribeiro
Journal: Blood (2020)
In Pursuit of Surrogate Markers for Treatment-Free Remission in Patients with Chronic Myeloid Leukemia from Argentina Stop Trial
Authors: Maria Belen Sanchez, Beatriz Moiraghi, Ana Ines Varela, Estrella Levy, Masiel Vera, Bianca Vasconcelos Cordoba, Isabel Giere, Josefina Freitas, Veronica Ventriglia, Maria Del Rosario Custidiano, Ana Garcia de Labanca, Georgina Bendek, Romina Mariano, María Jose Mela Osorio, Mariana Juni, Maximiliano Riddick, Miguel A. Pavlovsky, Maria Cecilia Foncuberta, Jose Mordoh, Isolda I. Fernandez, Julio Cesar Sanchez Avalos, Carolina Pavlovsky, Michele Bianchini
Journal: Blood (2020)
The Prognostic Importance of the 6-Minute Walk Test in AL Amyloidosis
Authors: Oliver C Cohen, Ananth Sathyanath, Sriram Ravichandran, Steven Law, Richa Manwani, Darren Foard, Sajitha Sachchithanantham, Shameem Mahmood, Ana Martinez-Naharro, Marianna Fontana, Carol Whelan, Philip N Hawkins, Helen J Lachmann, Julian D Gillmore, Ashutosh D. Wechalekar
Journal: Blood (2020)
Mitochondria Define Intestinal Stem Cell Differentiation Downstream of a FOXO/Notch Axis
Authors: Marlies C. Ludikhuize, Maaike Meerlo, Marc Pages Gallego, Despina Xanthakis, Mar Burgaya Julià, Nguyen T.B. Nguyen, Eline C. Brombacher, Nalan Liv, Madelon M. Maurice, Ji-hye Paik, Boudewijn M.T. Burgering, Maria J. Rodriguez Colman
Journal: Cell Metabolism (2020)

Differential WNT and Notch signaling regulates differentiation of Lgr5+ crypt-based columnar cells (CBCs) into intestinal cell lineages. Recently we showed that mitochondrial activity supports CBCs, while adjacent Paneth cells (PCs) show reduced mitochondrial activity. This implies that CBC differentiation into PCs involves a metabolic transition toward downregulation of mitochondrial dependency. Here we show that Forkhead box O (FoxO) transcription factors and Notch signaling interact in determining CBC fate. In agreement with the organoid data, Foxo1/3/4 deletion in mouse intestine induces secretory cell differentiation. Importantly, we show that FOXO and Notch signaling converge on regulation of mitochondrial fission, which in turn provokes stem cell differentiation into goblet cells and PCs. Finally, scRNA-seq-based reconstruction of CBC differentiation trajectories supports the role of FOXO, Notch, and mitochondria in secretory differentiation. Together, this points at a new signaling-metabolic axis in CBC differentiation and highlights the importance of mitochondria in determining stem cell fate.
Defibrotide for the Treatment of Endotheliitis Complicating Sars-Cov-2 Infection: Rationale and Ongoing Studies As Part of the International Defacovid Study Group
Authors: Jose M. Moraleda, Carmelo Carlo-Stella, David Garcia-Bernal, Ruben Jara Rubio, Enriqueta Andreu, Eleonora Calabretta, Alessio Aghemo, Maribel Diaz-Ricart, Marta Palomo, Enric Carreras, Israel Vlodavsky, Massimo Iacobelli, Jawed Fareed, Pedro Castro, Sara Fernandez, Clifton C. Mo, Gerald L. Weinhouse, Kenneth R. Cooke, Robert J. Soiffer, Rebecca M. Baron, Peter O'Gorman, Gregory Yanik, Antonio Pagliuca, Paul G. Richardson
Journal: Blood (2020)
Results from a Phase 1 Dose Escalation Study of HMPL-689, a Selective Oral Phosphoinositide 3-Kinase-Delta Inhibitor, in Chinese Patients with Relapsed/Refractory (R/R) Lymphomas
Authors: Junning Cao, Zhiming Li, Jianfeng Zhou, Dongmei Ji, Weina Shen, Peng Sun, Yu Wang, Dengju Li, Zhenya Hong, Gaoxiang Wang, Xianlin Duan, Chen Yu, Yu Cai, Weiguo Su
Journal: Blood (2020)
Abstract 15023: Cardiovascular Magnetic Resonance Imaging-Based Multivariable Risk Score for the Prediction of Heart Failure Admission or Death
Authors: Aidan K Cornhill, Steven Dykstra, Yoko Mikami, Jacqueline Flewitt, Michelle Seib, Peter Faris, Matthew James, Carmen Lydell, Andrew Howarth, Bobby Heydari, Nowell Fine, Derek V Exner, Joon Lee, James White
Journal: Circulation (2019)

Introduction: Established heart failure (HF) risk scores lack patient-specific markers available from contemporary cardiovascular magnetic resonance (CMR). We developed a novel risk score, inclusiv...
Patterns and Risk of CNS Recurrence after R-EPOCH Treatment for Double/Triple Hit Lymphoma
Authors: Mohammad Ahsan Sohail, Hong Li, Wei Wei, Sebastian Cerdena, Marcus Watkins, Marissa Olson, Gray Jodon, Jeff Kaiser, Bradley Haverkos, Mitchell E. Hughes, Natalie S Grover, Anson Snow, Victor M. Orellana-Noia, Magdalena A Rainey, Matthew J Cortese, Joslyn Rudoni, Craig A. Portell, Timothy J Voorhees, Daniel J. Landsburg, Manali Kamdar, Brad S. Kahl, Brian T. Hill
Journal: Blood (2020)
Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVID-19
Authors: Dermot Phelan, Jonathan H. Kim, Michael D. Elliott, Meagan M. Wasfy, Paul Cremer, Amer M. Johri, Michael S. Emery, Partho P. Sengupta, Sanjay Sharma, Matthew W. Martinez, Andre La Gerche
Journal: JACC. Cardiovascular imaging (2020)
Abstract 520: Structural, Molecular, and Electrophysiological Maturation of Human Induced Pluripotent Stem Cell Derived Atrial Cardiomyocytes to Serve as a Model for Atrial Fibrillation
Authors: Olivia T Ly, Grace Brown, Liang HONG, Arvind Sridhar, Meihong Zhang, Hanna Chen, Seock Won Youn, khaled Abdelhady, Malek Massad, Zain Alzahrani, SALMAN KHETANI, Dawood Darbar
Journal: Circulation Research (2020)

Background: Atrial fibrillation (AF), the most common arrhythmia, is associated with significant morbidity and increased mortality. Although antiarrhythmic drugs are still commonly used to treat symptomatic AF, membrane-active drugs are incompletely and unpredictably effective, failing to target the underlying mechanisms of AF. Our pilot data shows atrial iPSC-CMs generated from a familial AF kindred recapitulated the electrophysiologic (EP) phenotype of an AF-linked SCN5A mutation, serving as a novel platform to target underlying cellular AF mechanisms. However, structural, molecular, and EP immaturity as compared to adult atrial CMs has hindered successful mechanistic evaluation. Objective: We aim to determine optimal condition(s) to enhance the maturity of atrial iPSC-CMs, establishing them as a novel platform to model AF, elucidate the cellular mechanisms, and identify/assess novel, mechanism based therapies. Methods: Maturity of atrial iPSC-CMs was enhanced using TID (T3, IGF-1, dexamethasone), fatty acids (FA), acute electrical stimulation (ES), and extracellular matrix (ECM) modulation. We examined for improvements in structural maturity (immunofluorescence, transmission electron microscopy), molecular (qPCR, RNA seq) and EP (patch clamping, multi-electrode array, high-throughput automated patch clamping). The maturity of atrial iPSC-CMs was compared with adult atrial CMs obtained from the same patient during cardiac surgery. Results and Conclusion: Fig. 1 demonstrates that acute ES, combined with TID and FA supplementation, significantly improves structural and in part EP maturity of atrial iPSC-CMs.
Covid-19: a fork in the road ahead for general practice or a knife severing the road behind?
Authors: Sati Heer-Stavert
Journal: BMJ (2020)

It’s hard to argue against the sentiments of continuity of care, longer consultations, and empathy in general practice put forward by Gray and colleagues,1 but it’s also hard to reconcile this wish list with the trend for flexible working, early retirement, …
Immunologic Characterization of Coronavirus Disease 2019 (COVID-19) Patients with Hematological Cancer: Biologic and Clinical Significance
Authors: Catarina Maia, Esperanza Martín-Sánchez, Juan José Garcés, Ascensión López-Diaz de Cerio, Susana Inogés, Manuel Landecho, Belen Gil-Alzugaray, Cristina Pérez Ruiz, Cirino Botta, Aintzane Zabaleta, Felix Alegre, César Rincón, Laura Blanco, Sarai Sarvide, Amaia Vilas-Zornoza, Diego Alignani, Cristina Moreno, Monica Olid, Andrés Blanco, Josepmaria Argemi, Bruno Paiva, Jose-Ramon Yuste
Journal: Blood (2020)
Neoantigens Are Typically Associated with Intact HLA Class I Presentation in Early-Stage Follicular Lymphoma
Authors: Hennes Tsang, Ann-Marie Patch, Colm Keane, Soi C. Law, Jay Gunawardana, Piers Blombery, Ella R Thompson, Muhammed B. Sabdia, Lilia Merida De Long, Clemence J Belle, Karthik Nath, Joshua W.D. Tobin, Stephen H Kazakoff, John F. Seymour, Michael MacManus, Maher K. Gandhi
Journal: Blood (2020)
KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Authors: Ian H. de Boer, M. Luiza Caramori, Juliana C.N. Chan, Hiddo J.L. Heerspink, Clint Hurst, Kamlesh Khunti, Adrian Liew, Erin D. Michos, Sankar D. Navaneethan, Wasiu A. Olowu, Tami Sadusky, Nikhil Tandon, Katherine R. Tuttle, Christoph Wanner, Katy G. Wilkens, Sophia Zoungas, Peter Rossing
Journal: Kidney International (2020)

The Kidney Disease: Improving Global Outcomes (KDIGO) 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents the first KDIGO guideline on this subject. The scope includes topics such as comprehensive care, glycemic monitoring and targets, lifestyle and antihyperglycemic interventions, and approaches to self-management and optimal models of care. The goal of the guideline is to generate a useful resource for clinicians and patients by providing actionable recommendations with infographics based on a rigorous, formal systematic literature review. Another aim is to propose research recommendations for areas in which there are gaps in knowledge. The guideline targets a broad audience of clinicians treating diabetes and CKD while taking into account implications for policy and payment. The development of this guideline followed an explicit process of evidence review and appraisal. Treatment approaches and guideline recommendations are based on systematic reviews of relevant studies, appraisal of the quality of the evidence, and the strength of recommendations following the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. Limitations of the evidence are discussed and areas for future research are presented.
The Combination of Ruxolitinib (RUX) with Decitabine (DAC) in Patients (Pts) with Post-Myeloproliferative Neoplasm Acute Myeloid Leukemia (post-MPN AML): Interim Report of a Phase I/II Trial
Authors: Rita Assi, Prithviraj Bose, Srdan Verstovsek, Yvonne Gasior, Nitin Jain, Elias J. Jabbour, Zeev Estrov, Yesid Alvarado, Courtney D. DiNardo, Naveen Pemmaraju, Steven Kornblau, Tapan Kadia, Naval Daver, Mark Brandt, Sherry Pierce, Xuelin Huang, Guillermo Garcia-Manero, Hagop M. Kantarjian, Farhad Ravandi
Journal: Blood (2017)
Secondary Graft-Versus-Host Disease (GVHD) Prophylaxis with Oral Proteasome Inhibitor Ixazomib Is Associated with Low Incidence of Recurrent, Late Acute and Chronic GVHD and Facilitated Calcineurin Inhibitor Taper within the First Year Post Allogeneic Stem Cell Transplantation
Authors: Natasia Rodriguez, Jasme Lee, Lisa Flynn, Fiona Murray, Sean Devlin, Cristina Soto Izquierdo, Christina Cho, Parastoo B. Dahi, Sergio A. Giralt, Craig S. Sauter, Miguel-Angel Perales, Doris M Ponce
Journal: Blood (2020)
Correlating Clinical and Genomic Features with E<i>x Vivo</i> Drug Sensitivity in Patients with Myelodysplastic Syndromes and Related Myeloid Neoplasms
Authors: Michael A Spinner, Steven A Schaffert, Alexey Aleshin, Marianne T Santaguida, Hiroomi Tada, Peter L. Greenberg
Journal: Blood (2020)
Characteristics Affecting Durability and Tolerability of Imatinib in Patients Switched from Brand to Generic and Newly Diagnosed Patients Initially Prescribed Generic Imatinib for Chronic Myeloid Leukemia
Authors: Ariel Denson, Kristyn Y. DiSogra, Justin Arnall, Srinivasa R. Sanikommu, Nilay A. Shah, Brittany K. Ragon, Thomas G. Knight, Jing Ai, Michael R. Grunwald, Belinda R Avalos, Edward A Copelan, Aleksander L. Chojecki
Journal: Blood (2020)
Abstract 236: Aldehydes in Cigarette Smoke Impair Vascular Endothelial Function
Authors: Poonam Rao, Pooneh Nabavizadeh Rafsanjani, Daniel Han, Suzaynn Schick, Matthew Springer
Journal: Circulation Research (2020)

Introduction: Exposure to tobacco and marijuana smoke impairs vascular endothelial function. While the particulate phase of smoke is heavily implicated, the role of volatile constituents is unclear. Smoke contains aldehydes, which are known to cause endothelial dysfunction. We explored whether two aldehydes found in smoke, acrolein and acetaldehyde, can induce endothelial dysfunction. Hypothesis: Aldehydes in smoke impair endothelial function. Methods: We exposed 4 groups of anesthetized rats to 3 ppm acrolein and 10-11.5 ppm acetaldehyde gases (concentrations relevant to levels in secondhand smoke), Marlboro Red cigarette sidestream smoke at modest levels (600 μg/m 3 PM2.5) as a positive control, and clean air through the gas generation system as a negative control. Exposure was continuous for 10 minutes. Endothelial function (flow-mediated dilation; FMD) was quantified pre- and post-exposure by measuring femoral artery diameter with ultrasound before and after 5 min of transient ischemia and expressed as % vasodilation. Results: Impairment of FMD was observed for acrolein (10.8±1.7(SD)% vs. 5.8±2.9%, p=.001), acetaldehyde (8.8±2.0% vs. 6.0±2.5%, p=.001), and cigarette smoke (9.4±2.9% vs. 5.8±2.0%, p=.002), but not for air (7.9±2.0% vs. 9±3.2%, p=.44) (figure; each colored line denotes a rat pre- and post-exposure; bars denote means). Conclusions: Acrolein and acetaldehyde at levels found in secondhand smoke impair endothelial function. Our results suggest that despite a potential role of particles, volatile aldehydes may mediate part of the endothelial dysfunction caused by exposure to smoke.
Durable Remissions and Increased Overall Survival in AML Patients Deemed Unfit for Standard Intensive Chemotherapy Achieved with High-Dose BST-236 (Aspacytarabine) Induction and Consolidation
Authors: Jessica K. Altman, Selina M. Luger, Olga Frankfurt, Tsila Zuckerman, Jamie L. Koprivnikar, Vamsi Kota, Ashkan Emadi, Bhavana Bhatnagar, Dale L. Bixby, Micah M. Burch, Ofir Wolach, Itai Levi, Anna Gourevitch, Ron Ram, Liat Flaishon, Shoshi Tessler, Stela Gengrinovitch, Ruth Ben Yakar, Jacob M. Rowe
Journal: Blood (2020)
B-Cell Acute Lymphoblastic Leukemia Arising in Patients with a Preexisting Diagnosis of Multiple Myeloma Is a Novel Cancer with High Incidence of TP53 Mutations
Authors: Monique Chavez, Erica Barnell, Malachi Griffith, Zachary Skidmore, Obi Griffith, Ling Tian, Lukas D Wartman
Journal: Blood (2020)
SAT0018 Pulmonary involvement in ankylosing spondylitis
Authors: PD Sampaio-Barros, L Maeda, SM Rezende, VA Zanardi, EF Cerqueira, JF Marques-Neto, JR Menezes-Neto, AM Samara
Journal: Annals of the Rheumatic Diseases (2001)

<h3>Background</h3> <h3>Objectives</h3> To analyse the subclinical pulmonary involvement in a series of patients with ankylosing spondylitis (AS). <h3>Methods</h3> Prospective study analysing 52 patients with the diagnosis of AS according to the modified New York criteria. The patients were asymptomatic about lung complaints and were submitted to a pulmonary investigation that included plain chest radiography, pulmonary function test (PFT) and thoracic high-resolution computed tomography (HRCT). The results were compared with sex, race, dorsal spine involvement, thoracic diameter, smoking status and HLA-B27. There was predominance of male (81%), Caucasoid (75%), non-smoking (64%) and positive HLA-B27 (75%) patients, with dorsal spine involvement in 58%. Mean age was 40 years and mean disease duration was 16 years. <h3>Results</h3> There were five patients (10%) with an altered plain chest radiography. PFT presented a restrictive pattern in 52% of the patients. Thoracic HRCT showed abnormalities in 21 patients (40%), predominantly nonspecific linear parenchymal opacities (19%), lymphadenopathy (12%), emphysema (10%), bronquiectasis (8%) and pleural involvement (8%). Male sex was statistically associated with dorsal involvement (p = 0.012). Non-Caucasoid race was associated with bronquiectasis (p = 0.044) and pleural involvement (p = 0.044) at the thoracic HRCT. Smoking patients presented more linear parenchymal opacities (p = 0.026) at the thoracic HRCT. Negative HLA-B27 was associated with an altered plain chest radiography (p = 0.011). Dorsal spine involvement was associated with restrictive pattern at PFT (p = 0.001) and linear parenchymal opacities (p = 0.032) at the thoracic HRCT. A lower thoracic diameter was observed in patients with dorsal spine involvement (p = 0.0001), restrictive pattern at PFT (p = 0.023) and linear parenchymal opacities (p = 0.015) at the thoracic HRCT. <h3>Conclusion</h3> Subclinical pulmonary involvement is frequent in AS. The restrictive pattern at PFT is associated with dorsal spine involvement and a low thoracic diameter, whilst the thoracic HRCT presents a series of nonspecific alterations, predominating the linear parenchymal opacities.
Problem Joints and Their Clinical and Humanistic Burden in Children and Adults with Moderate and Severe Hemophilia a: CHESS Paediatrics and CHESS II
Authors: Paul McLaughlin, Cedric Hermans, Sohaib Asghar, Tom Burke, Francis Nissen, Martynas Aizenas, Oliver Meier, Harpal Dhillon, Jamie O'Hara
Journal: Blood (2020)
Diet Quality at the Initiation of Treatment for Metastatic Colorectal Cancer
Authors: Cindy Kin
Journal: JAMA Network Open (2020)

Erin L. Van Blarigan, ScD; Sui Zhang, MS, MPP; Fang-Shu Ou, PhD; Alan Venlo, MD; Kimmie Ng, MD, MPH; Chloe Atreya, MD, PhD; Katherine Van Loon, MD, MPH; Donna Niedzwiecki, PhD; Edward Giovannucci, MD, ScD; Eric G. Wolfe, MD; Heinz-Josef Lenz, MD; Federico Innocenti, MD, PhD; Bert H. O’Neil, MD; James E. Shaw, MD; Blase N. Polite, MD; Howard S. Hochster, MD; James N. Atkins, MD; Richard M. Goldberg, MD; Robert J. Mayer, MD; Charles D. Blanke, MD; Eileen M. O’Reilly, MD; Charles S. Fuchs, MD, MPH; Jeffrey A. Meyerhardt, MD, MPH